1.18
Schlusskurs vom Vortag:
$1.15
Offen:
$1.22
24-Stunden-Volumen:
2.12M
Relative Volume:
15.55
Marktkapitalisierung:
$5.31M
Einnahmen:
$9.37M
Nettoeinkommen (Verlust:
$-8.45M
KGV:
-1.4568
EPS:
-0.81
Netto-Cashflow:
$-7.27M
1W Leistung:
+7.27%
1M Leistung:
-13.87%
6M Leistung:
-85.28%
1J Leistung:
-95.32%
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BIAF
Bioaffinity Technologies Inc
|
1.18 | 5.17M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
515.12 | 192.95B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
211.25 | 147.43B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
630.73 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
126.34 | 35.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
328.66 | 32.13B | 3.17B | 642.63M | 539.81M | 10.77 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
bioAffinity Highlights CyPath Lung Case Study in Diagnostics - TipRanks
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer - The Joplin Globe
bioAffinity Highlights CyPath Lung Clinical Utility in Surveillance - TipRanks
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study - BioSpace
Setup Watch: What is bioAffinity Technologies Inc Equity Warrants valuation compared to sectorForecast Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Can bioAffinity Technologies Inc. Equity Warrant weather a recession2025 Historical Comparison & Safe Entry Momentum Tips - mfd.ru
How bioAffinity Technologies Inc. Equity Warrant stock performs in weak economyMarket Sentiment Summary & Risk Controlled Daily Trade Plans - mfd.ru
Is bioAffinity Technologies Inc.’s growth already priced in - mfd.ru
Growth Recap: Will bioAffinity Technologies Inc outperform tech stocksTrade Ideas & Technical Buy Zone Confirmations - baoquankhu1.vn
Will bioAffinity Technologies Inc. benefit from AI trends2025 Investor Takeaways & Low Volatility Stock Suggestions - mfd.ru
Momentum Shift: What is the implied volatility of bioAffinity Technologies IncEntry Point & Intraday High Probability Alerts - baoquankhu1.vn
bioAffinity Technologies Updates Investor Presentation Materials Online - The Globe and Mail
Can bioAffinity Technologies Inc. stock continue upward trendTrade Analysis Report & Accurate Buy Signal Notifications - mfd.ru
bioAffinity Technologies expands medical advisory board with lung experts By Investing.com - Investing.com South Africa
bioAffinity Adds Leading Lung Cancer Experts to Advisory Board - TipRanks
bioAffinity Technologies Appoints New Advisory Board Members - TradingView
bioAffinity Technologies Appoints Three Physicians to Medical and Scientific Advisory Board - citybiz
bioAffinity Technologies expands medical advisory board with lung experts - Investing.com
BioAffinity Technologies, Inc. Announces Medical and Scientific Advisory Board Appointments - marketscreener.com
bioAffinity Sets 2026 Annual Meeting, Revives Prior Proposals - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
AI Stocks: Is bioAffinity Technologies Inc affected by consumer sentimentWeekly Risk Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Bank Watch: Will bioAffinity Technologies Inc benefit from sector rotationJuly 2025 Fed Impact & Fast Entry Momentum Alerts - baoquankhu1.vn
Gainers Report: Can bioAffinity Technologies Inc Equity Warrant outperform under higher oil prices2025 Winners & Losers & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Aug Patterns: Will bioAffinity Technologies Inc outperform tech stocksJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Market Recap: Can bioAffinity Technologies Inc Equity Warrant weather a recessionWeekly Trade Analysis & High Accuracy Swing Trade Signals - baoquankhu1.vn
Is bioAffinity Technologies Inc. stock a value trap2025 Breakouts & Breakdowns & Weekly Return Optimization Alerts - mfd.ru
Aug Fed Impact: Is FingerMotion Inc in a long term uptrendWeekly Gains Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Patterns Watch: Is bioAffinity Technologies Incs growth already priced in - baoquankhu1.vn
Aug Analyst Calls: What is bioAffinity Technologies Inc Equity Warrants valuation compared to sectorEarnings Miss & AI Optimized Trade Strategies - baoquankhu1.vn
Stock Recap: What are the future prospects of bioAffinity Technologies Inc Equity WarrantJuly 2025 Sentiment & Consistent Income Trade Ideas - baoquankhu1.vn
Earnings Recap: What are the future prospects of bioAffinity Technologies Inc Equity WarrantEarnings Overview Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Market Trends: Is bioAffinity Technologies Incs growth already priced inShare Buyback & Weekly Top Gainers Alerts - baoquankhu1.vn
bioAffinity Adjourns Special Stockholder Meeting for Lack Quorum - MSN
Why bioAffinity Technologies Inc. Equity Warrant stock appeals to dividend seekersPortfolio Value Report & Fast Entry Momentum Alerts - Улправда
Will bioAffinity Technologies Inc. stock pay special dividendsJuly 2025 Sector Moves & Low Risk High Win Rate Picks - Улправда
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - FinancialContent
Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growth2025 Key Lessons & Weekly Momentum Picks - Улправда
Is bioAffinity Technologies Inc. stock trading at a premium valuation2025 Dividend Review & Advanced Technical Analysis Signals - ulpravda.ru
Will bioAffinity Technologies Inc. stock outperform tech sector in 2025Quarterly Growth Report & Free Fast Entry Momentum Trade Alerts - Улправда
Is bioAffinity Technologies Inc. Equity Warrant stock cheap compared to fundamentalsJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - Улправда
Is bioAffinity Technologies Inc. stock ready for breakoutJuly 2025 Weekly Recap & AI Driven Price Predictions - ulpravda.ru
Can bioAffinity Technologies Inc. stock maintain growth trajectoryWeekly Market Summary & Detailed Earnings Play Strategies - Улправда
Is bioAffinity Technologies Inc. Equity Warrant stock a buy for dividend growthMarket Volume Summary & AI Powered Market Trend Analysis - ulpravda.ru
Will bioAffinity Technologies Inc. stock attract ESG investorsWeekly Trade Summary & Stock Timing and Entry Methods - Улправда
Will bioAffinity Technologies Inc. Equity Warrant stock attract ESG investors2025 Fundamental Recap & Daily Chart Pattern Signals - Улправда
How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peersFundamental Stock Analysis & Small Entry Cost Stocks - Улправда
bioAffinity Labs Maintain CAP Accreditation, Supporting CyPath Lung - TipRanks
bioAffinity Technologies Maintains CAP Accreditation - TradingView — Track All Markets
bioAffinity Technologies (BIAF) lab unit keeps College of American Pathologists accreditation - Stock Titan
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):